CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475617627
- Phone
- (617) 231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-25 | White Lauren Chief Financial Officer | Option exercise | +3,750 | 3,750 | ||
| 2022-05-25 | White Lauren Chief Financial Officer | Option exercise · Performance Restricted Stock Units | −3,750 | 22,500 | ||
| 2022-05-25 | Hirsch Andrew President & CEO | Option exercise | +12,500 | 22,500 | ||
| 2022-05-25 | Hirsch Andrew President & CEO | Option exercise · Performance Restricted Stock Units | −12,500 | 75,000 | ||
| 2022-04-12 | Fisher Stewart Chief Scientific Officer | Option exercise | +2,156 | $3.71 | $8K | 45,462 |
| 2022-04-12 | Fisher Stewart Chief Scientific Officer | Option exercise | +25,928 | $4.98 | $129K | 71,390 |
| 2022-04-12 | Fisher Stewart Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −2,156 | 35,572 | ||
| 2022-04-12 | Fisher Stewart Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −25,928 | 48,152 | ||
| 2022-04-12 | Hirsch Andrew President & CEO | Purchase | +10,000 | $8.40 | $84K | 10,000 |
| 2022-04-04 | Dubin Glenn Director | Grant or award | +379 | $26.46 | $10K | 873 |
| 2022-04-04 | COHEN ALAIN J Director | Grant or award | +388 | $26.46 | $10K | 928 |
| 2022-04-04 | Anderson Kenneth Carl Director | Grant or award | +341 | $26.46 | $9K | 88,316 |
| 2022-03-16 | Koppikar Utpal Director | Grant or award · Stock Option (Right to Buy) | +41,200 | 41,200 | ||
| 2022-02-23 | Hirsch Andrew President & CEO | Grant or award · Performance Restricted Stock Units | +87,500 | 87,500 | ||
| 2022-02-14 | Fisher Stewart Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +118,000 | 118,000 | ||
| 2022-02-14 | Fisher Stewart Chief Scientific Officer | Grant or award · Performance Restricted Stock Units | +26,250 | 26,250 | ||
| 2022-02-14 | Siegel Jolie Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2022-02-14 | Siegel Jolie Chief Legal Officer | Grant or award · Performance Restricted Stock Units | +26,250 | 26,250 | ||
| 2022-02-14 | White Lauren Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-02-14 | White Lauren Chief Financial Officer | Grant or award · Performance Restricted Stock Units | +26,250 | 26,250 |
Page 17 of 27 · 525 trades